CLEAR RESULTS WITH SOTYKTU

SOTYKTU was put to the test in clinical studies—here are the findings

Actor portrayal of a SOTYKTU® patient looking over her shoulder, smiling.

CLEARER SKIN AT 16 WEEKS

In one study, a majority of people taking SOTYKTU saw 75% CLEARER SKIN at Week 16 vs those taking placebo (53% vs 9%).

Skin clearance was also measured in a different way in that study, where half of people taking SOTYKTU saw CLEAR OR
ALMOST CLEAR SKIN at Week 16 vs 9% taking placebo.

In the same study, 16% of people saw COMPLETELY CLEAR SKIN at Week 16 compared to 1% taking placebo.

Your results may vary.

 SOTYKTU® once-daily pill winking face mascot.
SOTYKTU was studied in two large clinical trials:
  • 1684 adults were studied
  • 841 received SOTYKTU, 422 received Otezla® (apremilast), and 421 received placebo (a pill with no medicine)
  • Patients were assessed at 16, 24, and 52 weeks
See photos of real patients treating their moderate to severe plaque psoriasis with SOTYKTU

WHEN TOPICALS AREN'T ENOUGH, ASK FOR SOTYKTU

START LOVING YOUR SCALP INSTEAD OF HIDING IT

In one study, more people found A CLEAR OR ALMOST CLEAR SCALP with SOTYKTU vs Otezla at 16 weeks.

At 16 weeks, 70% of patients with psoriasis plaques on their scalp found a clear or almost clear scalp with once-daily SOTYKTU® versus 39% who saw a clear or almost clear scalp after taking twice-daily OTEZLA®.

In a second study, at 16 weeks, 60% of people taking SOTYKTU saw a clear or almost clear scalp vs 37% taking Otezla.

CLEARER SKIN FOR NEARLY 2X AS MANY PEOPLE VS THE LEADING PILL

In one study, more people saw 90% clearer skin with SOTYKTU vs Otezla at 24 weeks.

At 16 weeks, 70% of patients with psoriasis plaques on their scalp found a clear or almost clear scalp with once-daily SOTYKTU® versus 39% who saw a clear or almost clear scalp after taking twice-daily OTEZLA®.

In a second study, 32% of people taking SOTYKTU saw 90% clearer skin vs 20% taking Otezla.

Your results may vary.

Moderate to severe plaque psoriasis is a systemic disease.

RELIEF FROM A WIDE

RANGE OF SYMPTOMS

In studies, more adults taking SOTYKTU (8% vs 1% for placebo) reported complete relief of psoriasis symptoms (itch, pain, burning, stinging, skin tightness) at Week 16 compared to placebo.

SOTYKTU® relieves symptoms of plaque psoriasis such as itching, pain, burning, skin tightness, and stinging.

Your results may vary.

RESULTS THAT CAN LAST

In a different study, most people saw 75% clearer skin with SOTYKTU at 1 year. In a continuation of that study, a majority of people saw 75% clearer skin with SOTYKTU at 5 years.*

72% of people experienced 75% clearer skin at 1 year and 72% of people experienced 75% clearer skin at 4 years.
* In a follow-up study at 1 year and thereafter, 485 patients received continuous SOTYKTU through 5 years. Patients and physicians were aware of SOTYKTU treatment, which may have influenced their results.
Your results may vary.

 

REAL PEOPLE, REAL PHOTOS

See photos of real patients treating their moderate to severe plaque psoriasis with SOTYKTU.

START THE CONVERSATION

If you’re interested in SOTYKTU, ask your dermatology specialist about it.


Bristol Myers Squibb corporate website

SOTYKTU, SOTYKTU 360 SUPPORT, and SOTYKTU logo are trademarks of Bristol-Myers Squibb Company.
All other trademarks are property of their respective owners.
© 2025 Bristol-Myers Squibb Company.

This website is intended for U.S. residents 18 years of age or older.

1787-US-2500206 07/25